MedBright AI Investments Inc. Announces LIFE & Special Warrant Offering up to Approximately C$2,800,000

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/

VANCOUVER, BC, Jan. 24, 2024 /CNW/ - MedBright AI Investments Inc. (CNSX:MBAI.CN) (OTC-BB:MBAIF) ("MedBright" or the "Company"), is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. to act as sole bookrunner and lead agent (the "Lead Agent") in connection with the Offering (as defined below). The Lead Agent, on behalf of a syndicate including Beacon Securities Limited and PI Financial Corp., will assist the Company on (a) a "commercially reasonable efforts" agency basis private placement offering (the "LIFE Offering") of up to 6,994,887 units of the Company (the "LIFE Units") at a price of C$0.20 per LIFE Unit for gross proceeds of up to C$1,398,977.40; and (b) a "commercially reasonable efforts" agency basis private placement offering (the "Special Warrant Offering", and together with the LIFE Offering, the "Offering") of up to 7,000,000 special warrants of the Company (the "Special Warrants") at a price of C$0.20 per Special Warrant for gross proceeds of up to C$1,400,000. Each Special Warrant shall be exercisable for one unit of the Company (each, a "Special Warrant Unit", and together with the LIFE Units, the "Units") at no additional cost.